BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31586179)

  • 1. Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index.
    Rios JS; Greenwood EA; Pavone MEG; Cedars MI; Legro RS; Diamond MP; Santoro N; Sun F; Robinson RD; Christman G; Zhang H; Huddleston HG
    J Clin Endocrinol Metab; 2020 Jan; 105(1):e555-63. PubMed ID: 31586179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women.
    Jahromi BN; Dabbaghmanesh MH; Bakhshaie P; Parsanezhad ME; Anvar Z; Alborzi M; Zarei A; Bakhshaei M
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):555-559. PubMed ID: 30122578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
    Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.
    Vagios S; James KE; Sacha CR; Hsu JY; Dimitriadis I; Bormann CL; Souter I
    Fertil Steril; 2021 Jan; 115(1):229-237. PubMed ID: 33077236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Müllerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome].
    Durmanova AK; Otarbaev NK
    Ter Arkh; 2016; 88(12):41-44. PubMed ID: 28139558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women.
    Wissing ML; Mikkelsen AL; Kumar A; Kalra B; Pors SE; Flachs EM; Andersen CY
    Fertil Steril; 2019 Jul; 112(1):149-155.e1. PubMed ID: 31056306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome.
    Kriseman M; Mills C; Kovanci E; Sangi-Haghpeykar H; Gibbons W
    J Assist Reprod Genet; 2015 Sep; 32(9):1313-6. PubMed ID: 26238387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome.
    Yang JH; Chou CH; Yang WS; Ho HN; Yang YS; Chen MJ
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):686-92. PubMed ID: 26700986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone.
    Jaswa EG; Rios JS; Cedars MI; Santoro NF; Pavone MEG; Legro RS; Huddleston HG
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3234-42. PubMed ID: 32756952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
    Pearce K; Gleeson K; Tremellen K
    Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.